New Delhi, July 14 -- Anthem Biosciences has initiated its initial public offering (IPO) today, (Monday, July 14). The IPO will close on Wednesday, July 16, and the bidding for anchor investors is set for July 11, as outlined in the red herring prospectus (RHP).

This IPO is solely an offer-for-sale (OFS) amounting to Rs.3,395 crore from promoters, investors, and other selling shareholders.

As the IPO is completely an OFS, the company will not acquire any funds from the offering, and the proceeds will be directed to the selling shareholders.

In the Anthem Biosciences IPO, 50% of the offering is allocated for qualified institutional buyers (QIB), 15% for non-institutional investors (NII), and 35% for retail investors. A total of Rs.8.25 ...